ClinicalTrials.gg
CompletedNCT02702622Updated Aug 31, 2016

Vitamin A Equivalence of the Provitamin A in Biofortified Bananas

An interventional study of Provitamin A-biofortified transgenic bananas in Vitamin A Deficiency, sponsored by Iowa State University. Completed. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-08-31.

Sponsored by Iowa State University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The objective will be to quantify the vitamin A equivalence of the provitamin A in transgenic biofortified bananas.

02

Conditions studied

  • Vitamin A Deficiency

Browse trials for

Keywords

  • bananas
  • biofortified
  • carotenoids
  • vitamin A
03

In context

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

Browse Vitamin A Deficiency studies →

Lead sponsor

Iowa State University is the lead sponsor of 37 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • General good health as determined by interview, blood biochemistry profile, and complete blood count
  • Antecubital veins amenable to blood collection

Exclusion criteria

Exclusion Criteria:

  • Adverse reactions to blood sample collection
  • History of anemia or excessive bleeding
  • Cigarette smoking, frequent alcohol consumption
  • Use of vitamin/mineral supplements
  • Food allergies
  • Lactose intolerance
  • Abnormal thyroid status
  • Chronic disease, lipid malabsorption or gastrointestinal disorders
  • Hyper- or hypolipidemia
  • (BMI) > 28
  • History of eating disorder or restrained eating
  • Current or planned pregnancy; menstrual cycle irregularities or abnormalities
  • Use of hormonal (affects chylomicron clearance); use of medications that may affect lipid absorption or transport
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable

Interventions

  • OtherProvitamin A-biofortified transgenic bananas
06

What researchers measure

Primary outcomes

  1. Area under the curve for retinyl ester in the plasma triacylglycerol-rich lipoprotein fraction

    Time frame: 0 - 9.5 hours postprandially

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2016 and a primary completion of Jun 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2016
First posted
Mar 8, 2016
Start
Mar 2016
Primary completionActual
Jun 2016
Last update
Aug 31, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02702622
Lead sponsor
Iowa State University
Responsible party
Wendy S. White (Associate Professor, Iowa State University) — Principal investigator
First posted
Mar 8, 2016
Start date
Mar 2016
Primary completion
Jun 2016
Last update
Aug 31, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion